DR. MATTHEW K FLYNN M.D. NPI 1689678336

NPI Details

DR. Matthew K Flynn, M.D. is a specialist in Raleigh, NC with 29 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Matthew K Flynn, M.D. NPI is 1689678336. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: DUKE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1996

The provider's business location address is:

5603 DURALEIGH RD
STE 111
RALEIGH, NC
ZIP 27612-688
Phone: (919) 791-0840
Fax: (919) 791-0911

The NPI 1689678336 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:17271)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Biopsy of ear (HCPCS:69100)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:17281)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/10/2005 and was last updated on 11/12/2009.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.